Given the identification of markers (e.g., TMB, immune signatures, and PD-L1 expression) predictive of both ICI response and irAEs risk in our study, we propose that the association between response and irAEs risk may be partially linked via high tumor immunogenicity and immunoresponsive microenvironment represented by these predictors. This evidence concerns the gene CD274 and neoplasm.